Hello everyone here! First of all, I want to apologize for my absence and the lack of updates during last week. I had a small health issue that forced me to disconnect and prioritize rest, but we are back at 100% and ready to get moving again.
While the market does not stop, neither does our operation. This is how we are moving the pieces right now:
Use of Leverage and Operating Capital: We continue using leverage tools and capital provided by the platform to strengthen our positions. This requires strict monitoring of overall P&L and a meticulous management of risk, knowing that discipline is what keeps the ship afloat.
Rotation and Technical Filters:
We have added positions with a growth and technical analysis profile such as $SMCI (Super Micro Computer), looking to take advantage of its momentum under our guidelines.
We continue testing and adjusting other tactical and value alternatives such as $PFEon (Pfizer) and $ACAD (ACADIA Pharmaceuticals), evaluating their real behavior in the short and medium term.
Flexibility of the Method: The market is never linear. The real advantage is not in being right all the time, but in the ability to adapt to variability: if a thesis needs to be adjusted, capital is rotated and lessons are learned along the way.
The trading journey is about this: resilience, health above all, and constant evolution based on data and risk management.
How is your trading week going? What assets are you monitoring? I’ll read you in the comments! 👇
#Trading #PortfolioUpdate #SMCI #PFE #ACAD #RiskManagement #Leverage #BinanceSquare #GrowthJourney
While the market does not stop, neither does our operation. This is how we are moving the pieces right now:
Use of Leverage and Operating Capital: We continue using leverage tools and capital provided by the platform to strengthen our positions. This requires strict monitoring of overall P&L and a meticulous management of risk, knowing that discipline is what keeps the ship afloat.
Rotation and Technical Filters:
We have added positions with a growth and technical analysis profile such as $SMCI (Super Micro Computer), looking to take advantage of its momentum under our guidelines.
We continue testing and adjusting other tactical and value alternatives such as $PFEon (Pfizer) and $ACAD (ACADIA Pharmaceuticals), evaluating their real behavior in the short and medium term.
Flexibility of the Method: The market is never linear. The real advantage is not in being right all the time, but in the ability to adapt to variability: if a thesis needs to be adjusted, capital is rotated and lessons are learned along the way.
The trading journey is about this: resilience, health above all, and constant evolution based on data and risk management.
How is your trading week going? What assets are you monitoring? I’ll read you in the comments! 👇
#Trading #PortfolioUpdate #SMCI #PFE #ACAD #RiskManagement #Leverage #BinanceSquare #GrowthJourney